We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+38.8%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$3.79B
AUM Growth
+$1.43B
Cap. Flow
+$661M
Cap. Flow %
17.45%
Top 10 Hldgs %
59.79%
Holding
60
New
6
Increased
1
Reduced
4
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 65.98%
2 Industrials 13.91%
3 Technology 12.25%
4 Real Estate 4%
5 Consumer Discretionary 1.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DM
1
DELISTED
Desktop Metal, Inc.
DM
$489M 12.91%
+2,841,609
New +$376M
ALLK
2
DELISTED
Allakos
ALLK
$303M 8%
2,164,704
-103,484
-5% -$10.8M
EAR
3
DELISTED
Eargo, Inc. Common Stock
EAR
$292M 7.72%
+326,047
New +$275M
CRSP icon
4
CRISPR Therapeutics
CRSP
$4.62B
$243M 6.43%
1,590,002
NET icon
5
Cloudflare
NET
$94.9B
$212M 5.6%
2,763,583
NKTX icon
6
Nkarta
NKTX
$152M
$179M 4.72%
2,904,974
OPEN icon
7
Opendoor
OPEN
$3.69B
$152M 4%
+6,888,766
New +$144M
RYTM icon
8
Rhythm Pharmaceuticals
RYTM
$7.38B
$143M 3.77%
4,912,306
SPT icon
9
Sprout Social
SPT
$533M
$140M 3.71%
3,090,080
-2,506,000
-45% -$119M
OYST
10
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$112M 2.94%
5,925,287
BDTX icon
11
Black Diamond Therapeutics
BDTX
$94.5M
$111M 2.92%
3,449,845
PANW icon
12
Palo Alto Networks
PANW
$256B
$95.5M 2.52%
+1,612,104
New +$75.3M
ADAP
13
DELISTED
Adaptimmune Therapeutics
ADAP
$92.1M 2.43%
17,082,611
ELVN icon
14
Enliven Therapeutics
ELVN
$3.8B
$88.6M 2.34%
1,004,293
ARDX icon
15
Ardelyx
ARDX
$1.25B
$88.2M 2.33%
13,633,582
AKUS
16
DELISTED
Akouos Inc
AKUS
$85.2M 2.25%
4,298,488
TRIL
17
DELISTED
Trillium Therapeutics Inc.
TRIL
$84.4M 2.23%
5,736,363
MIRM icon
18
Mirum Pharmaceuticals
MIRM
$6.69B
$73.1M 1.93%
4,187,801
AUPH icon
19
Aurinia Pharmaceuticals
AUPH
$1.93B
$71.5M 1.89%
5,172,683
ANNX icon
20
Annexon
ANNX
$798M
$62.5M 1.65%
2,497,661
INZY
21
DELISTED
Inozyme Pharma
INZY
$50.5M 1.33%
2,444,379
GRTX
22
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$44.6M 1.18%
4,362,986
CSPR
23
DELISTED
Casper Sleep Inc.
CSPR
$38.3M 1.01%
6,226,130
BE icon
24
Bloom Energy
BE
$48B
$38.2M 1.01%
1,333,333
VRNA
25
DELISTED
Verona Pharma
VRNA
$35.8M 0.94%
5,108,563

Similar funds

NEA Management Company's Q4 2020 Portfolio in Review

As of Q4 2020, NEA Management Company held 60 positions worth $3.79B, up 60% from $2.36B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

NEA Management Company deployed $661M of net new capital in Q4 2020, opening 6 new positions and adding to 1 existing holding. Its largest new stake was Desktop Metal, Inc.: 2,841,609 shares worth $489M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 84% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Sprout Social, an estimated $119M trimmed.

  • NEA Management Company's largest Q4 2020 buy was Desktop Metal, Inc.: 2,841,609 shares worth $489M.
  • NEA Management Company added most to Regulus Therapeutics in Q4 2020, an estimated $3.23M increase.
  • NEA Management Company's biggest Q4 2020 reduction was Sprout Social, cutting an estimated $119M.
  • NEA Management Company fully exited Mersana Therapeutics in Q4 2020, selling an estimated $111M.
  • NEA Management Company's ten largest holdings make up 60% of its $3.79B portfolio in Q4 2020.
  • NEA Management Company opened 6 new positions and closed 3 in Q4 2020.
  • NEA Management Company's portfolio value rose 60% quarter-over-quarter to $3.79B.

Based on NEA Management Company's 13F filing for Q4 2020, filed 16 Feb 2021.